Sign In
  • ENG

A common epilepsy drug can prevent nerve damage in patients with multiple sclerosis

The University College London study found that the drug phenytoin slowed the progress of optic neuritis, a symptom leading to blurred vision.

Written by Agencies |Published : February 1, 2016 10:00 AM IST

A commonly-used epilepsy drug has brought hope for multiple sclerosis sufferers as it may help prevent nerve damage. The University College London study found that the drug phenytoin slowed the progress of optic neuritis, a symptom leading to blurred vision, and scientists believe it could have a similar protective effect throughout the brain. Currently there are no neuroprotective drugs available for MS sufferers, whose nerve fibres are attacked by their own immune system. (Read: Ketogenic diet for preventing epileptic attacks)

In the study, 86 people with acute optic neuritis were either given phenytoin or an inactive placebo 'dummy drug' for three months and at the end of the trial, the group who received the genuine drug had on average 30 percent less damage to the nerve fibre layer at the back of the eye. Lead researcher Dr Raj Kapoor said that these are promising results and if the findings are confirmed by larger, Phase III trials, could lead to a new treatment that protects nerves from the damage caused both in optic neuritis and throughout the central nervous system in other attacks of MS. The findings are reported in the journal The Lancet Neurology. (Read: Can vitamin D3 treat multiple sclerosis?)

Source: ANI

Also Read

More News

Photo source: Getty images (Image for representational purpose only)


Total Wellness is now just a click away.

Follow us on